Search

Sartorius Stedim Biotech.

Open

SectorFinance

169.5 3.61

Overview

Share price change

24h

Current

Min

161.1

Max

166.2

Key metrics

By Trading Economics

Income

41M

88M

Sales

-11M

762M

P/E

Sector Avg

65.054

22.624

EPS

1.17

Profit margin

11.569

Employees

10,456

EBITDA

32M

230M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+41.36% upside

Dividends

By Acuity

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-632M

18B

Previous open

165.89

Previous close

169.5

News Sentiment

By Acuity

67%

33%

388 / 438 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

27 Jul 2026, 23:56 UTC

Correlated Moves
News

Diamondback Energy gained during after-market hours, buoyed by strong revenue growth and a favorable market position, with shares peaking above Monday's close.

27 Jul 2026, 23:51 UTC

News
Event

UDR Inc reported second-quarter net income of $69.035 million. Shares declined in after-market trading amid concerns over flat revenue and rising costs.

27 Jul 2026, 23:51 UTC

News

L3Harris Technologies has secured Pentagon agreements to boost missile defense production, but shares are trading lower in after-market hours.

27 Jul 2026, 23:51 UTC

News
Social Media

Tesla Inc shares declined in after-market trading, continuing a trend of lower closes over the past four sessions amid analyst caution following its Q2 performance.

27 Jul 2026, 23:51 UTC

News

Rivian shares rise in after-market trading as analysts upgrade outlook and boost price target ahead of earnings report on July 30.

27 Jul 2026, 23:51 UTC

News

Cincinnati Financial Corp shares fell in after-market hours following second-quarter results that missed expectations for EPS and revenue. Earlier in the session, shares briefly rose.

27 Jul 2026, 23:51 UTC

News
Social Media

Cadence Design Systems shares are higher in after-market trading following strong Q2 results and an increase in full-year revenue guidance to $6.26 billion to $6.34 billion.

27 Jul 2026, 23:51 UTC

News
Social Media

Microstrategy shares declined in after-market hours following Peter Schiff's criticism of the company's Bitcoin yield, which fell significantly in recent months.

27 Jul 2026, 23:51 UTC

News

Accenture PLC shares are lower in after-market hours despite a $2 billion share repurchase program and a quarterly dividend announcement.

27 Jul 2026, 23:51 UTC

News

NIO shares rose in after-market trading, building on regular-session gains. Options activity showed bullish sentiment, with calls outpacing puts significantly.

27 Jul 2026, 23:51 UTC

News
Social Media
Correlated Moves

Micron Technology Inc shares declined in after-market trading following a report raising concerns about the company's growth potential and future demand for memory chips.

27 Jul 2026, 23:51 UTC

News
Social Media

Amkor Technology's shares declined in after-market trading following weaker-than-expected third-quarter revenue guidance despite strong second-quarter results and earnings.

27 Jul 2026, 23:42 UTC

News
Correlated Moves

Bitcoin is trading lower as easing geopolitical tensions reduce demand for safe-haven assets. Ethereum also declines, reflecting its correlation with Bitcoin's market movements.

27 Jul 2026, 23:42 UTC

Correlated Moves
News

Bitcoin is trading lower as easing geopolitical tensions reduce demand for safe-haven assets. Ethereum also declines amid similar market dynamics.

27 Jul 2026, 23:41 UTC

News
Correlated Moves

NBT Bancorp shares are higher in after-market trading following second-quarter results, which included net income of $53 million and a dividend increase to $0.40 per share.

27 Jul 2026, 23:41 UTC

News
Social Media

Brown & Brown Inc reported second-quarter revenues of $1.68 billion, missing expectations. Shares are trading lower in after-market hours following the mixed results.

27 Jul 2026, 23:41 UTC

News

OPKO Health reported second-quarter revenues of $163.5 million, surpassing expectations. The company also raised its full-year sales guidance, boosting shares in after-market trading.

27 Jul 2026, 23:41 UTC

News

International Paper shares are higher in after-market trading as CEO Andy Silvernail prepares to present at the Jefferies 2026 Industrials Conference on September 10.

27 Jul 2026, 23:41 UTC

News

Oil prices are higher in after-market hours, supported by reduced supply disruption concerns from the Middle East and gains in European markets.

27 Jul 2026, 23:31 UTC

News

Northwest Bancshares reported second-quarter adjusted EPS of $0.37 and revenue of $181.2 million, exceeding expectations. Shares are trading higher in after-market hours.

27 Jul 2026, 23:31 UTC

News
Social Media

Johnson & Johnson shares are higher in after-market trading following a proposed $5.5 billion settlement for ovarian talc litigation involving about 76,000 claims.

27 Jul 2026, 23:31 UTC

News
Social Media

ServiceNow shares rose during after-market hours as software stocks recovered. CEO Bill McDermott reported no slowdown in demand amid mixed social media sentiment on AI impacts.

27 Jul 2026, 23:26 UTC

News

Nucor Corporation reported second-quarter earnings of $1.16 billion, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

27 Jul 2026, 23:16 UTC

News
Social Media

Intel Corp shares are lower in after-market hours following a $2.1 billion loss, despite a 25% revenue increase to $16.1 billion in Q2.

27 Jul 2026, 23:16 UTC

News

Dell Technologies Inc. shares are lower in after-market hours, continuing a trend from the previous three sessions amid a focus on AI-optimized infrastructure solutions.

27 Jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

27 Jul 2026, 23:11 UTC

News

Albertsons Companies Inc shares are lower in after-market hours amid an investigation into potential securities law violations and a Q1 EPS miss of $0.42.

27 Jul 2026, 23:02 UTC

News
Social Media

Welltower reported strong Q2 results, raising full-year FFO guidance and increasing its dividend. Shares are trading higher in after-market hours.

27 Jul 2026, 23:02 UTC

News
Social Media

Sanmina Corp shares are lower in after-market trading despite strong Q3 results, as Q4 guidance fell short of consensus estimates.

27 Jul 2026, 23:02 UTC

News

GoPro Inc. will release its Q2 financial results on August 10, 2026, contributing to a higher after-market price as investors anticipate insights.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

41.36% upside

12 Months Forecast

Average 230 EUR  41.36%

High 260 EUR

Low 210 EUR

Based on 4 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Sentiment

By Acuity

388 / 438 Finance

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat